News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
253 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (4)
2 (2)
3 (20)
4 (246)
5 (293)
6 (243)
7 (134)
8 (6)
9 (6)
10 (245)
11 (212)
12 (305)
13 (245)
14 (103)
15 (11)
16 (7)
17 (226)
18 (253)
19 (250)
20 (220)
21 (147)
22 (16)
23 (11)
24 (235)
25 (299)
26 (248)
27 (114)
28 (103)
29 (10)
30 (46)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Career Advice
Why You Should Update LinkedIn Profile Regularly
You should regularly update LinkedIn profile to give the best outlook to the recruiters looking at your profile. Here are some more reasons to consider.
September 18, 2018
·
2 min read
·
Katie Roth, SHRM-SCP, SPHR
Business
Novo Nordisk to Lay off 400 to Focus on Innovation
Novo Nordisk is laying off 400 staffers so it can shift funds toward biological and technological innovation.
September 18, 2018
·
3 min read
·
Mark Terry
Drug Development
Allergan and Sosei Halt Alzheimer’s Trial Over Safety Concerns
Allergan and its development partner Sosei Group have voluntarily suspended clinical trials of HTL0018318 in Alzheimer’s and other types of dementia because of safety problems.
September 18, 2018
·
2 min read
·
Mark Terry
Policy
Novartis Ties Ethics Scoring System With Annual Bonuses
As Novartis looks to regain its reputation following a series of ethical blunders, the company unveiled a new ethics scoring system that will be tied to employee bonuses.
September 18, 2018
·
3 min read
·
Alex Keown
Deals
More Changes to the Pharmacy Industry Coming as DOJ Approves Cigna-Express Scripts Deal
In March, U.S. insurer Cigna Corporation announced it was acquiring pharmacy benefits manager Express Scripts for approximately $52 billion. On Monday, the Department of Justice (DOJ) approved the merger.
September 18, 2018
·
3 min read
·
Mark Terry
Drug Development
57% of Americans OK with Genetically Engineering Animals for Organ Transplants
A recent survey by the Pew Research Center found that 57 percent of Americans surveyed thought it was appropriate to use genetically engineered animals to grow organs for human transplants.
September 18, 2018
·
4 min read
·
Mark Terry
Policy
Senate Overwhelmingly Passes Bill to Address Prescription Opioids
In a 99 to 1 vote, the Senate passed the bill that looks to cut down on the flow of illegal narcotics entering the United States through the mail, as well as taking aim at the abuse of prescription opioid medication – a problem that has grown to an epidemic in the United States.
September 18, 2018
·
3 min read
·
Alex Keown
Policy
Second Scientist Pleads Guilty to Stealing GlaxoSmithKline Trade Secrets
A second former GlaxoSmithKline scientist has pled guilty to stealing trade secrets as part of a scheme to benefit a startup China-based pharmaceutical company he helped establish.
September 18, 2018
·
2 min read
·
Alex Keown
Drug Development
NASH Race Heats up as Viking Therapeutics Announces Stellar Phase II Data
San Diego-based Viking Therapeutics announced positive top-line data from a 12-week Phase II clinical trial of VK2809 in non-alcoholic fatty liver disease (NAFLD) and elevated low-density lipoprotein cholesterol (LDL-C).
September 18, 2018
·
3 min read
·
Mark Terry
Deals
Biotech IPOs Are Booming … but for How Long?
According to BioPharmCatalyst, there have been (or soon will be) 58 biopharma initial public offerings (IPOs) in 2018, and there’s still more than three months to go.
September 18, 2018
·
4 min read
·
Mark Terry
1 of 26
Next